The largest database of trusted experimental protocols

20 protocols using sodium deoxycholate

1

Protein Extraction and Immunoblotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were collected in RIPA buffer (10 mM Tris-HCl (pH 8.0), 1% (w/v) NP40, 0.1% (w/v) sodium deoxycholate (Wako), 0.1% (w/v) SDS (Wako), 0.15 M NaCl (Wako), 1 mM EDTA, 10 mM NaF (Wako), 1.5 mM Na3VO4 (Wako), and cOmplete™ Protease Inhibitor Cocktail (Roche)). Protein concentrations were titered using the BCA protein assay kit (Thermo Fisher Scientific). Collected protein lysate was mixed with SDS-PAGE loading buffer (0.15 M Tris-HCl, 6% (w/v) SDS, 0.003% (w/v) bromophenol blue (Wako), 30% (w/v) glycerol (Wako), and 15% (w/v) β-mercaptoethanol (Wako)) and then boiled at 95 °C for 5 min, followed by SDS-PAGE and immunoblotting. Antibodies used for immunoblotting were as follows: anti-milk (rabbit, 1:1000; Nordic-MUbio, Susteren, the Netherlands), anti-PyMT (rat, 1:500; Santa Cruz), anti-mCherry (rabbit, 1:500; Abcam), anti-histone H3 (rabbit, 1:2500; Cell Signaling Technology, MA, USA), and anti-α-tubulin (mouse, 1:5000; Calbiochem).
+ Open protocol
+ Expand
2

Dissection and Homogenization of Brain Regions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seven coronal sections of the brain at 2 mm thickness were made, and the third section from the rostral side was collected for the following dissection. The coronal section was dissected into two regions, cerebral cortex and striatum (S), for both hemispheres. The cerebral cortex was further divided into the non-ischemic (N) and ischemic (C) regions. Samples of the six regions in the coronal section were defined as: LN, region of the left cerebral cortex corresponding with the non-ischemic region in the right hemisphere; LC, region of the left cerebral cortex corresponding with the ischemic region in the right hemisphere; LS, striatum in left hemisphere; RN, non-ischemic region of the cerebral cortex in right hemisphere; RC, ischemic region of the cerebral cortex in right hemisphere; and RS, striatum in right hemisphere. Dissected sections were homogenized in lysis buffer (1% Triton X-100; MP Biomedicals (Santa Ana, CA, USA), 0.1% sodium deoxycholate; Wako (Osaka, Japan), 1% EDTA; DOJINDO (Kumamoto, Japan), Complete protease inhibitor cocktail; Roche (Basel, Switzerland), PhosStop phosphatase inhibitor cocktail; Roche, in 50 mM Tris-buffered saline) with Ultrasonic Liquid Processor Q 125 (QSONICA) for 20 s at 4 °C. The homogenate was centrifuged at 15,000 × g for 5 min at 4 °C, and the supernatant was collected for immunoblotting.
+ Open protocol
+ Expand
3

TLR2 Expression in LPS-Stimulated PEFs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PEFs_SV40 cells were cultured in 10% FBS DMEM and stimulated with or without 0.1 μg/mL L-LPS for 3 h and 72 h. To obtain total protein extract, cells were lysed in solution which containing 50 mM Tris-HCl (pH 7.4), 0.15 M NaCl, 1% Triton X-100, 2.5 mg/mL sodium deoxycholate (Wako Pure Chemical Industries, Osaka, Japan), and a protease inhibitor cock-tail (1:200 dilution, Nacalai-tesque). After calibrating the total protein concentration of cell lysate by a DC Protein assay reagent (Bio-Rad Laboratories, Hercules, CA, USA), 10 μg proteins was subjected to SDS-PAGE (ATTO Corporation, Tokyo, Japan) and blotted onto polyvinylidene fluoride membrane (Immobilon-P; Millipore Corporation, MA, USA). The membrane was blotted using the polymer immunocomplexes method as described previously (Fukuda et al., 2000 (link)). TLR2 protein expression level was detected with the ECL chemiluminescence Western blot system for immunostaining (GE healthcare, Buckinghamshire, UK). Anti-α-tubulin antibody (dilution 1:1,000, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) was used as a loading control.
+ Open protocol
+ Expand
4

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To extract proteins from WT, K4D, and K4DT cells, we lysed cells in a buffer containing 50 mM Tris–HCl (pH 7.4), 0.15 M NaCl, 1% Triton X-100, 2.5 mg/mL sodium deoxycholate (Wako, Osaka, Japan), and a protease inhibitor cocktail (1/200 dilution, Nacalai Tesque). Total cell lysates were separated by SDS-PAGE and then transferred to PVDF membranes (Merck, Darmstadt, Germany). After the membranes were blocked with 1% nonfat dry milk with 0.05% Tween 20, they were probed with mouse anti-human CDK4 (1:2500, #sc-56277; Santa Cruz Biotechnology, Dallas, TX, USA), Cyclin D1 (1:5000, #553; MBL, Nagoya, Japan), and α-tubulin (1:1000, #sc-32293; Santa Cruz Biotechnology) antibodies. HRP-conjugated goat anti-mouse IgG (1:2000, #330; MBL) or HRP-conjugated goat anti-rabbit IgG (1:2000, #458; MBL) was used as a secondary antibody. Immunoreactive signals were detected using an Image Quant LAS-4000 mini system (GE Healthcare, Little Chalfont, UK) with Pierce ECL Western Blotting Substrate (Thermo Fisher Scientific).
+ Open protocol
+ Expand
5

Quantitative Bile Acid Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vancomycin hydrochloride, polymyxin B sulfate, lithocholic acid, sodium deoxycholate, sodium taurocholate, and lysyl endopeptidase were purchased from Wako Pure Chemical Industries (Osaka, Japan). QIAamp Fast DNA Stool Mini Kit was from Qiagen (Hilden, Germany). Taq DNA polymerase containing 10 × Standard buffer (Taq) and dNTPs were obtained from BioAcademia (Osaka, Japan) and synthesised PCR primers were obtained from FASMAC (Kanagawa, Japan). Sodium taurolithocholate and sodium taurochenodeoxycholate were purchased from Sigma-Aldrich (St. Louis, MO, USA). Taurodeoxycholic acid sodium salt was purchased from Nacalai Tesque (Kyoto, Japan). Tauro β-muricholic acid sodium salt was purchased from Steraloids (Newport, RI, USA). Taurocholic acid-d5 (TCA-d5) sodium salt was purchased from Toronto Research Chemicals (Toronto, Ontario, Canada). Triglyceride Quantification Assay kit was purchased from Abcam (Cambridge, UK). Plasma Membrane Protein Extraction Kit was obtained from BioVision (Milpitas, CA, USA). Pierce BCA Protein Assay Kit was obtained from Thermo Fisher Scientific (Waltham, MA, USA). Sequencing-grade modified trypsin (frozen) was obtained from Promega (Madison, WI, USA). Synthesised isotope-labelled peptides were obtained from Sigma-Aldrich. Other reagents were commercially available products of reagent or analytical grade.
+ Open protocol
+ Expand
6

3D Ultrastructural Analysis of Acellular Glomeruli

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the 3D ultrastructural findings of GBM surface, acellular glomeruli after acellular treatment, that is, digestion of all cellular components, were prepared as described previously [17 (link), 18 (link)]. The small renal cortex tissues (2–3 mm3) were sequentially exposed to 5 mM EDTA (Sigma Aldrich Corp, St. Louis, MO, USA) for 24 h (h), 3% Triton X-100 (Sigma Aldrich Corp, St. Louis, MO, USA) for 18 h, 0.025% deoxyribonuclease (Worthington Biochemical Crop. Lakewood, USA) in 1 M NaCl for 6 h, and 4% sodium deoxycholate (FUJIFILM Wako Pure Chemical Corp Tokyo, Japan) for 18 h. After t-butyl alcohol vacuum drying, freeze-dried specimens were coated with gold powder and examined by SEM (SU3500, Hitachi, Tokyo, Japan) and LV-SEM (Hitachi Tabletop Microscope TM3030 plus, Hitachi High-Technologies Corp., Tokyo, Japan). Acellular glomeruli stained with uranyl acetate and lead citrate or PAM were also examined by TEM.
+ Open protocol
+ Expand
7

Phosphoproteome Enrichment and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed and harvested with ice-cold PBS. The proteins were extracted with phase-transfer surfactant (34 (link)) using a lysis buffer (12 mM sodium deoxycholate [Fujifilm Wako], 12 mM sodium N-lauroylsarcosinate [Fujifilm Wako], 100 mM Tris-HCl [pH 9.0], containing protein phosphatase inhibitor cocktail 1 and 2 [Sigma-Aldrich], and protease inhibitors [Sigma-Aldrich]). Protein amount was determined with a BCA protein assay kit, and the proteins were reduced with 10 mM DTT for 30 min and then alkylated with 50 mM iodoacetamide for 30 min in the dark. After reduction and alkylation, proteins were digested with Lys-C (w/w 1:100) for 3 h, followed by trypsin digestion (w/w 1:100) overnight at 37 °C. Then, the peptides were desalted using SDB-XC StageTip.
Phosphopeptides were enriched from 100 μg of tryptic peptides by means of TiO2-based hydroxy-acid-modified metal oxide chromatography (HAMMOC) (35 (link)) and eluted with 0.5% piperidine. Phosphopeptides were labeled with tandem mass tag (TMT) (Thermo Fisher Scientific), desalted using SDB-XC StageTips, fractionated at basic pH (33 (link)), and suspended in the loading buffer (0.5% TFA and 4% ACN) for subsequent LC/MS/MS analyses.
+ Open protocol
+ Expand
8

Cisplatin-Loaded Nanoparticle Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols

Cisplatin was purchased from Wako Pure Chemical Industries Co., Ltd. (Tokyo, Japan). Egg phosphatidylcholine (EPC, Coatsome® NC-50) and Tween 80 were products of NOF Inc. (Tokyo, Japan). Sodium Deoxycholate (SD) was acquired from Wako Pure Chemical Industries Co., Ltd. (Osaka, Japan). Sodium cholate (SC) was supplied by Sigma Aldrich (Tokyo, Japan). The diblock polymer used in this experiment was polyethylene oxide-b-polymethacrylic acid (PEO-b-PMAA; Mw of PEO = 7500; Mn of PMAA= 11 000) was obtained from Polymer Source, Inc. (Canada). Saline was purchased from Otsuka Co. Ltd. (Japan). In order to undertake high-performance liquid chromatography (HPLC) analysis, all solvents were of HPLC analytical grade. For graphite furnace atomic absorption spectrophotometry (GF-AAS) measurements, nitric acid (1.38; analytical grade, Wako Pure Chemical Industries Co., Ltd., Osaka, Japan) was employed as a digestive acid solution, while hydrochloric acid (AAS analytical grade) was used for the sample solvent (Kanto Chemical Co., Inc., Tokyo, Japan). The solvents; ethanol, methanol, acetone, and chloroform; were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). All other reagents and solvents employed in this study were of the highest quality available. Milli-Q water was used in all experiments.
+ Open protocol
+ Expand
9

Isolation and Culture of Primary Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hygromycin B Gold was purchased from InvivoGen Co. (San Diego, CA, USA). HEPES was purchased from Dojindo Laboratories (Kumamoto, Japan). Hank's balanced salt solution was purchased from Sigma-Aldrich (St. Louis, MO, USA). Deoxyribonuclease I from bovine pancreas, precrystalline, DISPASE II, NP-40 substrate, tris (hydroxymethyl) aminomethane, sodium deoxycholate, sodium dodecyl sulfate, chloroform, isopropyl alcohol, ethanol, NaHCO3, d-(+)-glucose, and 0.4 w/v % trypan blue solution were purchased from FUJIFILM Wako Pure Chemical Co. (Osaka, Japan). Collagenase D was purchased from Roche Diagnostics, Inc. (Mannheim, Germany). Fetal bovine serum (FBS) was purchased from Biosera (East Sussex, UK). Dulbecco's modified Eagle's medium (DMEM) was purchased from Nissui Pharmaceutical Co. Ltd. (Tokyo, Japan). Mitomycin C, a penicillin-streptomycin-glutamine mixed solution, and 100 mM sodium pyruvate solution (100 × ) were purchased from Nacalai Tesque Inc. (Kyoto, Japan). All the other chemicals used were of the highest commercially available grade.
+ Open protocol
+ Expand
10

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To extract proteins from primary, K4D, and K4DT + T cells, we lysed cells in a buffer containing 50 mM Tris–HCl (pH 7.4), 0.15 M NaCl, 1% Triton X-100, 2.5 mg/ml sodium deoxycholate (Wako, Osaka, Japan; cat. no. 194-08311), and a protease inhibitor cocktail (1/200 dilution, Nacalai Tesque; cat. no. 25955-11). The protein expression levels of CDK4 and Cyclin D were detected by Western blotting using an anti-CDK4 antibody (1/2,500 dilution, MBL, Nagoya, Japan; cat. no. 25955-11), an anti-cyclin D antibody (1/5,000 dilution, MB; cat. no. 553), and an anti-alpha-tubulin antibody (1/1,000 dilution, Santa Cruz Biotechnology, Dallas, TX, USA; cat. no. sc-32,293). Anti-mouse IgG (1/2,000 dilution, GE Healthcare, Buckinghamshire, UK; cat. no. NA931) or anti-rabbit IgG (1/2,000 dilution; GE Healthcare; cat. no. NA934-1ML) was used as secondary antibodies. The detailed Western blot procedure has been reported previously (Fukuda et al., 2005 (link), 2008 (link)). The intensity of signals was measured by the Image J software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!